Multiple sclerosis relapse risk factors across treatment eras
Predictors of future relapse did not differ substantially across treatment eras. Younger age and the use of less effective therapies were strong risk factors at FV. However, significant heterogeneity exists in individuals' relapse risk.
Authors
- Mariann Polgar‐Turcsanyi (ORCID: https://orcid.org/0000-0002-1244-1802)
- Brian C. Healy (ORCID: https://orcid.org/0000-0001-5272-2425)
- Evan Madill (ORCID: https://orcid.org/0009-0006-5482-1949)
- Tanuja Chitnis
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- Multiple Sclerosis Journal - Experimental Translational and Clinical
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/20552173251408619
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00